期刊文献+

凉血化瘀法干预老年性黄斑变性CNV与外周血CCR3表达的相关研究 被引量:5

Study of liangxue huayu in treatment of CNV in exudative age-related macular degeneration and expression of CCR3 on peripheral blood mononuclear cells
下载PDF
导出
摘要 目的:探讨凉血化瘀法治疗渗出型老年性黄斑变性CNV与外周血T淋巴细胞及嗜酸性粒细胞表面CCR3表达的关系。方法:以32例38眼渗出型老年性黄斑变性患者、44例73眼萎缩型老年性黄斑变性患者及50例健康人为观察对象,流式细胞术检测外周血T淋巴细胞及嗜酸性粒细胞表面CCR3的表达,对渗出型老年性黄斑变性患者予凉血化瘀中药治疗,比较治疗前后患者外周血CCR3的表达。结果:渗出型老年性黄斑变性患者外周血T淋巴细胞及嗜酸性粒细胞表面CCR3表达均高于健康对照组(P<0.01)。萎缩型老年性黄斑变性患者外周血CCR3表达和健康对照组没有显著性差异(P>0.05)。渗出型老年性黄斑变性患者治疗前后外周血CCR3的表达没有显著性差异(P>0.05)。结论:渗出型老年性黄斑变性CNV的形成可能与外周血T淋巴细胞及/或嗜酸性粒细胞表面CCR3的高表达有关,而凉血化瘀法能有效治疗渗出型老年性黄斑变性CNV,却与CCR3表达不相关。 · AIM: To compare the expressions of CCR3 on T lymphocytes and/or eosinophil peripheral blood cell surface before and after liangxue huayu in treatment of choroidal neovascularization (CNV) in exudative age- related macular degeneration (AMD) and explore the mechanism of the incidence of CNV on exudative AMD. · METHODS: Totally 32 cases of exudative AMD patients, 44 cases of atrophic AMD patients and 50 healthy subjects were observed. 32 cases of exudative AMD patients were treated by liangxue huayu decoction and the expressions of CCR3 on T lymphocytes and/or eosinophil peripheral blood cell surface were detected by flow cytometry. · RESULTS: The expressions of CCR3 on T lymphocytes and/or eosinophil peripheral blood cell surface of the patients with exudative AMD were higher than the control group of healthy people ( P〈 0, 01 ) ; The expressions of CCR3 on T lymphocytes and/or eosinophil peripheral blood cell surface were no significant difference between the patients with atrophic AMD and the control group of healthy people (P〉0.05) · The expressions of CCR3 on T lymphocytes and/or eosinophil peripheral blood cell surface were no significant difference after liangxue huayu on treatment of CNV on exudative AMD (P〉0. 05). · CONCLUSION: The CNV formation of exudative AMD may be related to the higher expressions of CCR3 on T lymphocytes and/or eosinophil cell surface. Liangxue huayu decoction is effective in treating exudative age-related macular degeneration CNV, but it is not related with the expression of CCR3.
出处 《国际眼科杂志》 CAS 2013年第3期546-548,共3页 International Eye Science
基金 福建省卫生厅中医药科研项目(No.wzzyb0903) 福建省教育厅项目(No.JA10077)~~
关键词 老年性黄斑变性 脉络膜新生血管 CCR3 凉血化瘀法 age-related macular degeneration choroidal neovascularization CCR3 liangxue huayu
  • 相关文献

参考文献11

  • 1王慧娟,唐由之.凉血化瘀方治疗湿性老年黄斑变性临床研究[J].中国中医眼科杂志,2008,18(6):322-324. 被引量:13
  • 2唐由之,周尚昆,冯俊,王慧娟.中药治疗湿性晚期老年性黄斑变性临床疗效观察[J].中国中医眼科杂志,2009,19(6):340-341. 被引量:32
  • 3李学晶,唐由之,张海涛.凉血化瘀中药治疗特发性脉络膜新生血管临床观察[J].国际眼科杂志,2009,9(11):2195-2197. 被引量:2
  • 4张承芬.眼底病学[M].北京:人民卫生出版社,1997.166.
  • 5全国眼底病研究协作组.老年性黄斑变性临床诊断标准.眼科新进展,1986,6(4):15-15.
  • 6Ambati J, Ambati BK, Y 00 SH, et al. Age - related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003 ;48 :257 -293.
  • 7Owen C. Chemokine receptors in airway disease: which receptors to target? Pulm Pharmacol Ther 2001 ; 14: 193-202.
  • 8Pease JE, Williams TJ. Chemokines and their receptors in allergic disease. J Allergy Clin Immunol 2006; 118 :305-318.
  • 9Willems 11, Ijzennan AP. Small molecule antagonists for chemokine CCR3 receptors. Med Res Rev 2010;30:778-817.
  • 10Salcedo R, Young HA, Ponce ML, et al . Eotaxin (CCLll) induces in vivo angiogenic responses by human CCR3 + endothelial cells. J Immunol2001 ; 166: 7571-7578.

二级参考文献37

共引文献94

同被引文献61

  • 1姜岩,何世坤.肿瘤坏死因子在年龄相关性黄斑变性脉络膜新生血管膜中的表达[J].眼科研究,2005,23(6):568-571. 被引量:3
  • 2Hua-hao SHEN Feng XU Gen-sheng ZHANG Shao-bin WANG Wei-hua XU.CCR3 monoclonal antibody inhibits airway eosinophilic inflammation and mucus overproduction in a mouse model of asthma[J].Acta Pharmacologica Sinica,2006,27(12):1594-1599. 被引量:8
  • 3KLEIN R J,ZEISS C,CHEW E Y,et al.Complement factor H polymor-phism in age-related macular degeneration[J].Science,2005,308(5720):385-389.
  • 4HAINES J L,HAUSER M A,SCHMIDT S,et al.Complement factor H variant in creases the risk of age-related macular degeneration[J].Science,2005,308(5720):419-421.
  • 5EDWARDS A O,RITTER R3rd,AEL K J,et al.Complement factor H polymor-phism and age-related macular degeneration[J].Science,2005,308(5720):421-424.
  • 6EDDON J M,GEORGE S,ROSNER B,et al.Progression of agerelated macular degeneration:prospective assessment of Creactive protein,interleukin 6,and other cardiovascular biomarkers[J].Arch ophthalmol,2005,123(6):774-782.
  • 7LIU B Y,WEI L,MEYERLE C,et al.Complement coponent C5a proments wxpression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration[J].Journal of translational medicine,2011,15(9):111.
  • 8DOYLE S L,OZAKI E M A,BRENNAN K,et al.IL-18attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration[J].Science translational medicine,2014,230(6):1-11.
  • 9COLLINS P D,CONNOLLY D T,WILLIAMS T J.Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo[J].Br j pharmacol,1993,109(1):195-199.
  • 10LU M,PEREZ V L,MA N,et al.VEGF increases retinal vascular ICAM-1 expression in vivo[J].Invest ophthalmol vis sci,1999,40(8):1808-1812.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部